Position
SIMPLEX TRADING, LLC in Apogee Therapeutics, Inc.
Back to the book · All holders of APGE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $545.7K$75.48 → $84.17
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 62.8K | $4.74M | — | — | — | 0.0% |
| Q1 2026 | 77.8K | $6.55M | $84.17 | $545.7K | $1.26M | 0.0% |